Clinical study patient id: (b)(6) it was reported that on (b)(6) 2019, a 25mm amplatzer patent foramen ovale (pfo) occluder was successfully implanted.When the patient visited the hospital for the one year regular postoperative follow up, a transesophageal echocardiogram was performed and no thrombus was observed on the occluder and no clinically significant subtle shunt flow was observed.On (b)(6) 2020, hemorrhagic stroke occurred.On (b)(6) 2021, the patient was hospitalized and the patient's clopidogrel was discontinued.The patient was discharged on (b)(6) 2021.
|